| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -27.6% | -64.9% |
| R&D Expense | $164.6M | +7.6% | +15.0% |
| SG&A Expense | $143.1M | +6.8% | -29.5% |
| Operating Income | -$306.2M | -7.5% | +10.4% |
| Pre-tax Income | -$159.0M | +40.9% | +29.1% |
| Income Tax | $7.0M | +50.5% | -43.9% |
| Net Income | -$113.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.24B | -0.1% | -36.8% |
| Short-term Investments | $3.15B | -3.5% | -8.1% |
| Current Assets | $4.51B | -2.3% | -22.2% |
| Total Assets | $5.06B | +0.6% | -18.4% |
| Current Liabilities | $133.9M | +17.6% | -75.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$390.0M | -90.8% | — |
| Capital Expenditures | $11.9M | +194.5% | — |
| Investing Cash Flow | -$965.3M | +11.1% | — |
| Financing Cash Flow | -$125.2M | +33.3% | — |
| Free Cash Flow | -$401.9M | -92.8% | — |
| +49.2% |
| +50.7% |
| EPS (Basic) | -$0.17 | +48.5% | +45.2% |
| EPS (Diluted) | -$0.17 | +48.5% | +45.2% |
| $257.1M |
| +18.7% |
| -58.9% |
| Stockholders' Equity | $4.36B | +0.4% | -15.3% |